Asset Management One
VNDA icon

Asset Management One’s Vanda Pharmaceuticals VNDA Stock Holding History

Asset Management One’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-23,905
Closed -$398K – 1211
2016
Q3 		$398K Buy
+23,905
New +$322K 0.01% 1098

Other funds holding VNDA

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Asset Management One's VNDA Position: Q4 2016 in Review

Asset Management One sold out of Vanda Pharmaceuticals (VNDA) in Q4 2016, closing a stake of 23,905 shares — an estimated $398K sold.

Asset Management One first reported a position in VNDA in Q3 2016 and held it in 1 quarter. The position peaked at $398K in Q3 2016. 141 funds tracked by Wall St. Rank hold VNDA as of Q4 2016.

  • Asset Management One reported no remaining Vanda Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Asset Management One sold 23,905 Vanda Pharmaceuticals shares in Q4 2016, an estimated $398K.
  • Asset Management One first reported a position in Vanda Pharmaceuticals in Q3 2016 and held it in 1 quarter.
  • Asset Management One's Vanda Pharmaceuticals position peaked at $398K in Q3 2016.
  • 141 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q4 2016.

Based on Asset Management One's 13F filing for Q4 2016, filed 13 Feb 2017.